Wave Life Sciences (WVE) Accumulated Expenses (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Accumulated Expenses data on file, last reported at $18.2 million in Q2 2026.

• Quarterly Accumulated Expenses rose 40.04% year-over-year to $18.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.2 million (up 40.04% YoY) and the FY2025 annual result came in at $26.6 million, up 26.01% from the prior year.
• Accumulated Expenses rose to $18.2 million in Q2 2026, from $13.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $26.6 million in Q4 2025 to a low of $6.6 million in Q1 2024.
• A 5-year average of $13.5 million and a median of $12.8 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses decreased 13.13% — and 2026, when it soared 66.94%.
• Tracing WVE's Accumulated Expenses over 5 years: stood at $17.6 million in 2022, then decreased by 4.12% to $16.8 million in 2023, then increased by 25.27% to $21.1 million in 2024, then climbed by 26.01% to $26.6 million in 2025, then plunged by 31.33% to $18.2 million in 2026.
• The last three Accumulated Expenses figures came in at $18.2 million (Q2 2026), $13.0 million (Q1 2026), and $26.6 million (Q4 2025), per Business Quant data.